ADP065-ABC

N/A

Report date: 2025/11/19 17:03:07
NME

Base Information

Drug NameADP065-ABC
Drug Alias NameADP065-ABCADP065ABC
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlector Llc
China Registration ClassN/A

Develop Information

Active CompaniesAlector Llc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A